StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) shareholders

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3014% below fair value
$27.81−1.07 (-3.70%)

Close on Nov 17, 2026Market cap $1.43BP/E –Yield 0.00%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
52M of 51M shares
Institutional holders
136
27 new, 31 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 10 sales
Net sold $5.63M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Wellington Investment Advisors Holdings LLP
Joint filing with Wellington Management Group LLP (11.60%), Wellington Group Holdings LLP (11.60%) and 1 more
5,959,77311.60%13G (passive) amendmentJun 30, 2026
Wellington Management Company LLP
Joint filing with Wellington Management Group LLP (10.20%), Wellington Group Holdings LLP (10.20%) and 1 more
5,132,89810.00%13G (passive) amendmentJul 31, 2025
RTW Investments, LP
Joint filing with Roderick Wong, M.D (9.70%)
4,869,7989.70%13G (passive) amendmentSep 30, 2024
Wellington Management Group LLP
Joint filing with Wellington Group Holdings LLP (9.10%), Wellington Investment Advisors Holdings LLP (9.10%) and 1 more
4,515,5249.10%13G (passive) amendmentJun 30, 2025
Jallal Bahija4,493,1398.20%13G (passive)Dec 31, 2024
Abigail P. Johnson
Joint filing with FMR LLC (8.80%)
4,307,2468.80%13G (passive) amendmentJun 30, 2026
Primecap Management Co/Ca/3,772,2347.51%13G (passive) amendmentJun 30, 2025
Bellevue Asset Management AG
Joint filing with Bellevue Group AG (5.60%)
2,796,8035.60%13G (passive)Aug 20, 2025
Vestal Point Capital, LP
Joint filing with Ryan Wilder (5.50%)
2,766,8685.50%13G (passive)Mar 31, 2026
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (5.20%), Point72 Capital Advisors, Inc. (5.20%)
2,720,0435.20%13G (passive)Nov 6, 2026
Kevin Tang
Joint filing with Tang Capital Management, LLC (5.20%)
2,605,6085.20%13G (passive)Oct 17, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IMCRValueChange% of portfolio
Wellington Management Group Llp5,721,94511.11%$181.67M+1,015,7770.03%
Rtw Investments, LP4,869,7989.46%$154.62M–1.32%
FMR LLC4,307,2468.36%$136.76M−521,9080.01%
Primecap Management Co/Ca/3,638,2417.06%$115.51M−55,0000.07%
Bellevue Group AG2,788,2455.41%$88.53M−8,5581.86%
Tang Capital Management LLC2,649,3685.14%$84.12M–3.82%
Vestal Point Capital, LP1,800,0003.50%$57.15M−966,8681.34%
Two Sigma Investments, LP1,648,9833.20%$52.36M+627,7180.04%
Millennium Management LLC1,597,0373.10%$50.71M+359,6340.02%
Armistice Capital, LLC1,428,0002.77%$45.34M+240,0000.55%
Caligan Partners LP1,381,3172.68%$43.86MNew2.06%
Kynam Capital Management, LP1,375,0002.67%$43.66M+490,0632.41%
Bvf Inc/Il1,294,4632.51%$41.10M–1.05%
Acadian Asset Management LLC1,209,8942.35%$38.39M+708,8030.05%
Trails Edge Capital Partners, LP1,063,2342.06%$33.76M+380,6375.36%
BlackRock, Inc.1,004,5981.95%$31.90M+348,2890.00%
Point72 Asset Management, L.P.990,2801.92%$31.44M−111,9910.03%
Price T Rowe Associates Inc /Md/831,0681.61%$26.39M−88,2640.00%
Jupiter Topco LLC709,0221.38%$22.50MNew0.01%
Cantor Fitzgerald, L. P.680,2001.32%$21.60M+429,9890.12%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202613652M100.0%27 / 5239 / 3111M10M
Q1 202614252M100.0%23 / 5144 / 289M9M
Q4 202514952M100.0%31 / 4839 / 105M2M
Q3 202513249M95.5%18 / 4148 / 184M3M
Q2 202513348M92.8%31 / 4541 / 136M6M
Q1 202511647M91.9%15 / 4333 / 144M2M
Q4 202411545M88.2%13 / 3744 / 275M4M
Q3 202413045M88.0%19 / 4739 / 278M5M
Q2 202413943M84.0%25 / 5835 / 3512M11M
Q1 202414943M83.2%29 / 6439 / 139M4M
Q4 202313339M75.0%23 / 5242 / 155M4M
Q3 202312537M71.7%14 / 5038 / 84M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

67 funds held IMCR in Q1 2026, 3% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of IMCRValue% of fundAs of
Vanguard Health Care Fund4,246,2748.25%$143.57M0.38%Jul 31, 2026
Vanguard Capital Opportunity Fund2,335,6504.54%$74.16M0.23%Jun 30, 2026
Fidelity Growth Company Fund1,121,6922.18%$32.41M0.03%May 31, 2026
PRIMECAP Odyssey Aggressive Growth Fund1,111,2002.16%$37.57M0.51%Jul 31, 2026
T. Rowe Price Health Sciences Fund, Inc.645,2681.25%$20.49M0.17%Jun 30, 2026
Select Health Care Portfolio500,0000.97%$14.45M0.25%May 31, 2026
Fidelity Growth Company K6 Fund330,3280.64%$9.54M0.03%May 31, 2026
MFS New Discovery Fund304,2950.59%$8.79M0.41%May 31, 2026
iShares Biotechnology ETF299,2880.58%$9.50M0.10%Jun 30, 2026
Select Biotechnology Portfolio287,2000.56%$8.30M0.16%May 31, 2026
Fidelity Series Growth Company Fund261,5700.51%$7.56M0.03%May 31, 2026
Fidelity Advisor Health Care Fund260,0000.50%$8.79M0.28%Jul 31, 2026
SmallCap Fund217,9000.42%$7.37M0.35%Jul 31, 2026
BlackRock Health Sciences Opportunities Portfolio188,6910.37%$5.45M0.09%May 29, 2026
Old Westbury Small & Mid Cap Strategies Fund159,8820.31%$5.41M0.06%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Bahija JallalCHIEF EXECUTIVE OFFICER, Director12,3430.02%Feb 19, 2026
Travis Alan CoyChief Financial Officer––Feb 19, 2026
Leger Tina Amber StCHIEF HR OFFICER1,1190.00%Feb 19, 2026
David M. BermanHEAD OF R&D5,8590.01%Feb 19, 2026
John GollSVP, FINANCE & CAO6530.00%Feb 19, 2026
Siddharth KaulDirector––May 28, 2026
Kristine PetersonDirector––May 28, 2026
William PaoDirector––May 28, 2026
Roy Steven HerbstDirector––May 28, 2026
Peter John RatcliffeDirector3330.00%May 28, 2026
John Irving BellDirector13,4520.03%May 28, 2026
Julian BakerDirector––May 19, 2025
Bros. Advisors Lp BakerDirector––May 19, 2025
Bros. Advisors (GP) LLC BakerDirector1,405,4212.73%May 19, 2025
Brothers Life Sciences LP BakerDirector––May 19, 2025
667, L.P.Director2,051,7113.98%May 19, 2025
Felix BakerDirector––May 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
John Goll
SVP, FINANCE & CAO
Feb 18, 2026Sale−698$32.35$22.58K653
David M. Berman
HEAD OF R&D
Feb 18, 2026Sale−5,965$32.35$192.97K5,859
Bahija Jallal
CHIEF EXECUTIVE OFFICER, Director
Feb 18, 2026Sale−11,474$32.35$371.18K12,343
Leger Tina Amber St
CHIEF HR OFFICER
Feb 18, 2026Sale−1,000$32.35$32.35K1,119
John Goll
SVP, FINANCE & CAO
Feb 17, 2026Option exercise+1,351––1,351
David M. Berman
HEAD OF R&D
Feb 17, 2026Option exercise+11,824––11,824
Bahija Jallal
CHIEF EXECUTIVE OFFICER, Director
Feb 17, 2026Option exercise+23,817––23,817
Leger Tina Amber St
CHIEF HR OFFICER
Feb 17, 2026Option exercise+2,119––2,119
David M. Berman
HEAD OF R&D
Dec 5, 2025Option exercise+572$17.46$9.99K572
David M. Berman
HEAD OF R&D
Dec 5, 2025Sale(10b5-1 plan)−572$40.14$22.96K0
David M. Berman
HEAD OF R&D
Dec 4, 2025Sale(10b5-1 plan)−31,341$40.26$1.26M0
David M. Berman
HEAD OF R&D
Dec 4, 2025Option exercise+31,341$17.46$547.21K31,341
David M. Berman
HEAD OF R&D
Nov 28, 2025Option exercise+5,521$17.46$96.40K5,521
David M. Berman
HEAD OF R&D
Nov 28, 2025Sale(10b5-1 plan)−5,521$40.09$221.34K0
David M. Berman
HEAD OF R&D
Nov 26, 2025Option exercise+69,404$17.46$1.21M69,404
David M. Berman
HEAD OF R&D
Nov 26, 2025Sale(10b5-1 plan)−69,404$40.12$2.78M0
David M. Berman
HEAD OF R&D
Nov 25, 2025Sale(10b5-1 plan)−18,020$40.03$721.34K0
David M. Berman
HEAD OF R&D
Nov 25, 2025Option exercise+18,020$17.46$314.63K18,020
David M. Berman
HEAD OF R&D
Nov 24, 2025Sale(10b5-1 plan)−100$40.00$4.00K0
David M. Berman
HEAD OF R&D
Nov 24, 2025Option exercise+100$17.46$1.75K100
David M. Berman
HEAD OF R&D
Sep 30, 2025Sale(10b5-1 plan)−61,849$35.23$2.18M0
David M. Berman
HEAD OF R&D
Sep 30, 2025Option exercise+61,849$17.46$1.08M61,849
David M. Berman
HEAD OF R&D
Sep 15, 2025Option exercise+200$17.46$3.49K200
David M. Berman
HEAD OF R&D
Sep 15, 2025Sale(10b5-1 plan)−200$35.01$7.00K0
David M. Berman
HEAD OF R&D
Sep 12, 2025Option exercise+22,532$17.46$393.41K22,532
David M. Berman
HEAD OF R&D
Sep 12, 2025Sale(10b5-1 plan)−21,232$35.63$756.50K1,300
David M. Berman
HEAD OF R&D
Sep 12, 2025Sale(10b5-1 plan)−1,300$36.31$47.20K0
David M. Berman
HEAD OF R&D
Sep 11, 2025Sale(10b5-1 plan)−19,081$36.28$692.26K0
David M. Berman
HEAD OF R&D
Sep 11, 2025Option exercise+19,081$17.46$333.15K19,081
David M. Berman
HEAD OF R&D
Sep 10, 2025Option exercise+31,338$17.46$547.16K31,338
David M. Berman
HEAD OF R&D
Sep 10, 2025Sale(10b5-1 plan)−30,138$36.12$1.09M1,200
David M. Berman
HEAD OF R&D
Sep 10, 2025Sale(10b5-1 plan)−1,200$36.77$44.12K0
667, L.P.
Director
Mar 17, 2025Buy+646,290$29.74$19.22M2,051,711
667, L.P.
Director
Mar 17, 2025Buy+8,589$29.56$253.89K178,596
667, L.P.
Director
Mar 17, 2025Buy+92,349$29.56$2.73M2,144,060
667, L.P.
Director
Mar 17, 2025Buy+60,110$29.74$1.79M170,007
Leger Tina Amber St
CHIEF HR OFFICER
Apr 1, 2024Sale(10b5-1 plan)−4,375$64.06$280.26K0
Leger Tina Amber St
CHIEF HR OFFICER
Apr 1, 2024Option exercise+4,375$29.87$130.68K4,375
David M. Berman
HEAD OF R&D
Feb 28, 2024Sale(10b5-1 plan)−7,472$68.84$514.37K12,137
David M. Berman
HEAD OF R&D
Feb 28, 2024Sale(10b5-1 plan)−10,937$69.73$762.64K1,200
David M. Berman
HEAD OF R&D
Feb 28, 2024Sale(10b5-1 plan)−1,200$70.45$84.54K0
David M. Berman
HEAD OF R&D
Feb 28, 2024Option exercise+36,509$17.46$637.45K36,509
David M. Berman
HEAD OF R&D
Feb 28, 2024Sale(10b5-1 plan)−16,900$67.61$1.14M19,609
David M. Berman
HEAD OF R&D
Feb 27, 2024Sale(10b5-1 plan)−4,448$69.45$308.91K50,490
David M. Berman
HEAD OF R&D
Feb 27, 2024Sale(10b5-1 plan)−3,394$71.97$244.27K0
David M. Berman
HEAD OF R&D
Feb 27, 2024Sale(10b5-1 plan)−25,944$71.32$1.85M3,394
David M. Berman
HEAD OF R&D
Feb 27, 2024Sale(10b5-1 plan)−21,152$70.42$1.49M29,338
David M. Berman
HEAD OF R&D
Feb 27, 2024Option exercise+54,938$17.46$959.22K54,938
David M. Berman
HEAD OF R&D
Feb 26, 2024Option exercise+28,553$17.46$498.54K28,553
David M. Berman
HEAD OF R&D
Feb 26, 2024Sale(10b5-1 plan)−26,516$70.60$1.87M2,037
David M. Berman
HEAD OF R&D
Feb 26, 2024Sale(10b5-1 plan)−2,037$71.31$145.26K0
Leger Tina Amber St
Chief HR Officer
Jan 3, 2024Option exercise+4,375$29.87$130.68K4,375
Leger Tina Amber St
Chief HR Officer
Jan 3, 2024Sale(10b5-1 plan)−4,068$69.85$284.15K307
Leger Tina Amber St
Chief HR Officer
Jan 3, 2024Sale(10b5-1 plan)−307$70.46$21.63K0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
8M shares short
Days to cover
14.2
At 1M shares a day
Change since last report
-0.1%
From 8M shares
Short volume, 20 days
29.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Immunocore's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,780 shares on Aug 20, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
David M. Berman
Affiliate
May 22, 202669,271$2.04MMay 22, 2026Same Day Cashless Exercise and Sale
David M. Berman
Affiliate
May 21, 202665,000$1.89MMay 21, 2026Same Day Cashless Exercise and Sale
David M. Berman
Affiliate
Apr 8, 202625,000$796.25KApr 8, 2026Same Day Cashless Exercise and Sale
David M. Berman
affiliate
Mar 11, 202611,832$385.33KMar 11, 2026Same Day Cashless Exercise and Sale
David M. Berman
affiliate
Feb 18, 20265,965$192.95KFeb 18, 2026RSU Vest
Leger Tina Amber St
affiliate
Feb 18, 20261,000$32.35KFeb 18, 2026RSU Vest
Bahija Jallal
affiliate
Feb 18, 202611,474$371.15KFeb 18, 2026RSU Vest
David M. Berman
Officer
Nov 24, 2025136,790$5.38MNov 24, 2025Stock Option Exercise
David M. Berman
Officer
Sep 10, 2025135,000$4.94MSep 10, 2025Stock Option Exercise
Donato Brian Di
affiliate
Mar 17, 2025100,000$3.00MMar 17, 2025Same Day Cashless Option Exercise and Sale
Donato Brian Di
affiliate
Mar 14, 202556,250$1.64MMar 14, 2025Same Day Cashless Option Exercise and Sale
Leger Tina Amber St
affiliate
Apr 1, 20244,375$280.28KApr 1, 2024Same Day Cashless Exercise and Sale
David M. Berman
affiliate
Feb 26, 2024120,000$8.48MFeb 26, 2024Same Day Cashless Exercise and Sale
Leger Tina Amber St
affiliate
Jan 3, 20244,375$262.50KJan 3, 2024Same Day Cashless Exercise and Sale
Bahija Jallal
affiliate
Dec 27, 202325,000$1.75MDec 27, 2023Same Day Cashless Exercise and Sale

See a number that looks wrong?